The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea

Purpose The goal of this study is to investigate the effects of androgen deprivation therapy (ADT) on total prostate volume and lower urinary tract symptoms (LUTS). Methods Between January 2007 and June 2014, 110 patients who received androgen deprivation treatment were enrolled in this retrospectiv...

Full description

Bibliographic Details
Main Authors: Hoon Choi, Hong Chung, Jae Young Park, Jeong Gu Lee, Jae Hyun Bae
Format: Article
Language:English
Published: Korean Continence Society 2016-12-01
Series:International Neurourology Journal
Subjects:
Online Access:http://www.einj.org/upload/pdf/inj-1632628-314.pdf
_version_ 1819130970318569472
author Hoon Choi
Hong Chung
Jae Young Park
Jeong Gu Lee
Jae Hyun Bae
author_facet Hoon Choi
Hong Chung
Jae Young Park
Jeong Gu Lee
Jae Hyun Bae
author_sort Hoon Choi
collection DOAJ
description Purpose The goal of this study is to investigate the effects of androgen deprivation therapy (ADT) on total prostate volume and lower urinary tract symptoms (LUTS). Methods Between January 2007 and June 2014, 110 patients who received androgen deprivation treatment were enrolled in this retrospective study. Clinical parameters and urodynamic parameters along with changes at follow-up were analyzed. Factors such as reduction in prostate volume, changes in LUTS, and prostate volume tertiles were compared 1 year after ADT. Results After ADT, the total International Prostate Symptom Score (IPSS) score decreased from 17.45 to 12.21 and the IPSS voiding subscore decreased from 9.16 to 6.24. Maximal uroflow rate increased from 8.62 to 11.50 mL/sec and residual urine also reduced significantly by 29.34 mL. Change in prostate size was more prominent (–51.14%) in the patients with less than 1 year of ADT (n=21) than those who had more than 1 year of treatment (n=89, –44.12%). The decrease in the IPSS voiding subscore was greater within 1 year of ADT than after 1 year of treatment (–4.10 vs. –2.65). The differences were more significant in the 30–50 g group (n=59) and >50 g group (n=11) than the <30 g group (n=40) of the IPSS voiding subscore improvement (–3.76 , –4.91 vs. –2.10), and maximal uroflow rate improvement (2.78, 2.90 vs 1.49). Conclusion ADT resulted in statistically significant clinical improvement in terms of prostate volume, urodynamic parameters, and LUTS for patients with prostate cancer when analyzed by ADT duration and prostate volume.
first_indexed 2024-12-22T09:08:04Z
format Article
id doaj.art-e431319f955842a2a7a6f34bc222fc1c
institution Directory Open Access Journal
issn 2093-4777
2093-6931
language English
last_indexed 2024-12-22T09:08:04Z
publishDate 2016-12-01
publisher Korean Continence Society
record_format Article
series International Neurourology Journal
spelling doaj.art-e431319f955842a2a7a6f34bc222fc1c2022-12-21T18:31:32ZengKorean Continence SocietyInternational Neurourology Journal2093-47772093-69312016-12-0120434234810.5213/inj.1632628.314637The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in KoreaHoon Choi0Hong Chung1Jae Young Park2Jeong Gu Lee3Jae Hyun Bae4 Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea Department of Urology, Konkuk University Hospital, Chungju, Korea Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, KoreaPurpose The goal of this study is to investigate the effects of androgen deprivation therapy (ADT) on total prostate volume and lower urinary tract symptoms (LUTS). Methods Between January 2007 and June 2014, 110 patients who received androgen deprivation treatment were enrolled in this retrospective study. Clinical parameters and urodynamic parameters along with changes at follow-up were analyzed. Factors such as reduction in prostate volume, changes in LUTS, and prostate volume tertiles were compared 1 year after ADT. Results After ADT, the total International Prostate Symptom Score (IPSS) score decreased from 17.45 to 12.21 and the IPSS voiding subscore decreased from 9.16 to 6.24. Maximal uroflow rate increased from 8.62 to 11.50 mL/sec and residual urine also reduced significantly by 29.34 mL. Change in prostate size was more prominent (–51.14%) in the patients with less than 1 year of ADT (n=21) than those who had more than 1 year of treatment (n=89, –44.12%). The decrease in the IPSS voiding subscore was greater within 1 year of ADT than after 1 year of treatment (–4.10 vs. –2.65). The differences were more significant in the 30–50 g group (n=59) and >50 g group (n=11) than the <30 g group (n=40) of the IPSS voiding subscore improvement (–3.76 , –4.91 vs. –2.10), and maximal uroflow rate improvement (2.78, 2.90 vs 1.49). Conclusion ADT resulted in statistically significant clinical improvement in terms of prostate volume, urodynamic parameters, and LUTS for patients with prostate cancer when analyzed by ADT duration and prostate volume.http://www.einj.org/upload/pdf/inj-1632628-314.pdfAndrogen Deprivation TherapyProstate NeoplasmsProstate Volume
spellingShingle Hoon Choi
Hong Chung
Jae Young Park
Jeong Gu Lee
Jae Hyun Bae
The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
International Neurourology Journal
Androgen Deprivation Therapy
Prostate Neoplasms
Prostate Volume
title The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
title_full The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
title_fullStr The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
title_full_unstemmed The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
title_short The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea
title_sort influence of androgen deprivation therapy on prostate size and voiding symptoms in prostate cancer patients in korea
topic Androgen Deprivation Therapy
Prostate Neoplasms
Prostate Volume
url http://www.einj.org/upload/pdf/inj-1632628-314.pdf
work_keys_str_mv AT hoonchoi theinfluenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT hongchung theinfluenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jaeyoungpark theinfluenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jeonggulee theinfluenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jaehyunbae theinfluenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT hoonchoi influenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT hongchung influenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jaeyoungpark influenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jeonggulee influenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea
AT jaehyunbae influenceofandrogendeprivationtherapyonprostatesizeandvoidingsymptomsinprostatecancerpatientsinkorea